WuXi AppTec · 7 hours ago
Business Development Manager, TIDES Catalog
WuXi AppTec is a company involved in the New Modality Business, and they are seeking a Business Development Manager to oversee activities in North America. The role focuses on developing strategies for existing and new accounts to increase sales and market share.
BiotechnologyHealth CareMedical DeviceOutsourcingPharmaceutical
Responsibilities
Develop plans and programs for existing accounts in his/her geography to gain market share in existing businesses, cross sell/promote other services and increase site penetration of all key accounts
Develop strategies and tactics to gain new business
Achieve PO targets for key accounts and new accounts
Record progress of BD activities in Salesforce and provide regular updates to management
Work closely with all WuXi business units, project management teams and marketing to ensure coordination of efforts and ensure good communication with all parties. Help set up BU visits, attend trade shows and stay involved when customers visit China
Collects and utilizes various data sources to provide competitive intelligence, tracking and analysis of the competitive landscape in assigned locations
Qualification
Required
Must be a self-starter, self-motivated, highly flexible, with excellent communication skills (verbal, written, and presentation skills). Must be organized and detail-oriented
Proven experience in creating successful business development plans and processes
Excellent communication skills, both verbal and written
Familiar with Salesforce (desired) and proficiency with MS Office Products to include Outlook, PowerPoint, Project, and Excel, are required
Preferred
Marketing experience preferred but not required
MS/PhD in Chemistry preferred, or equivalent training and/or experience in Oligonucleotide/Peptide chemistry
Master's in Business Administration (MBA) or Master's (MS) in Life Sciences is a plus, but not required
Company
WuXi AppTec
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Funding
Current Stage
Public CompanyTotal Funding
$1.59BKey Investors
Eight Roads Ventures
2025-03-03Acquired
2018-05-08IPO
2016-03-06Debt Financing· $1.5B
Recent News
Morningstar.com
2026-01-19
2026-01-15
2026-01-14
Company data provided by crunchbase